Cellectar Biosciences Reports Case Study Highlighting Complete Response Lasting More Than Eight Years in Heavily Pretreated DLBCL Patient Treated with Iopofosine I 131
Durable Complete Response Achieved with Single Administration of Iopofosine I 131
Durable Complete Response Achieved with Single Administration of Iopofosine I 131